News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Kelsey Stephen Michael
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/03/2023 |
4
| Kelsey Stephen Michael (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns:
| Sold 16,666 shares
@ $29.1913, valued at
$486.5k
Sold 16,666 shares
@ $32.4, valued at
$540k
|
|
08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/21/2022 |
4
| Kelsey Stephen Michael (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns:
| Sold 1,267 shares
@ $19.0426, valued at
$24.1k
|
|
06/22/2022 |
4
| Kelsey Stephen Michael (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns:
| Sold 1,145 shares
@ $17.7495, valued at
$20.3k
|
|
03/21/2022 |
4
| Kelsey Stephen Michael (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns:
| Sold 321 shares
@ $18.6162, valued at
$6k
|
|
03/03/2022 |
4
| Kelsey Stephen Michael (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns:
| Granted 38,800 shares
@ $0 Granted 135,800 options to buy
@ $18.56, valued at
$2.5M
|
|
12/21/2021 |
4
| Kelsey Stephen Michael (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns:
| Sold 343 shares
@ $24.41, valued at
$8.4k
|
|
09/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/08/2021 |
4
| Kelsey Stephen Michael (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns:
| Granted 15,000 shares
@ $0 Granted 52,500 options to buy
@ $42.45, valued at
$2.2M
|
|
11/18/2020 |
3
| Kelsey Stephen Michael (Director) has filed a Form 3 on Jiya Acquisition Corp. |
09/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/18/2020 |
4
| Kelsey Stephen Michael (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns:
| Sold 11,363 shares
@ $31.0267, valued at
$352.6k
Sold 637 shares
@ $31.032, valued at
$19.8k
|
|
09/10/2020 |
4
| Kelsey Stephen Michael (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns:
| Sold 600 shares
@ $29.015, valued at
$17.4k
Sold 800 shares
@ $29.0925, valued at
$23.3k
Sold 100 shares
@ $29.04, valued at
$2.9k
Sold 1,002 shares
@ $29.1619, valued at
$29.2k
Sold 1,540 shares
@ $29, valued at
$44.7k
Exercised 600 options to buy
@ $4.73, valued at
$2.8k
Exercised 1,002 options to buy
@ $4.73, valued at
$4.7k
|
|
09/03/2020 |
4
| Kelsey Stephen Michael (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns:
| Sold 2,021 shares
@ $26.4254, valued at
$53.4k
Sold 2,908 shares
@ $27.5436, valued at
$80.1k
Sold 5,071 shares
@ $28.2429, valued at
$143.2k
Sold 100 shares
@ $29.08, valued at
$2.9k
Sold 726 shares
@ $29.0158, valued at
$21.1k
Sold 700 shares
@ $29.0814, valued at
$20.4k
Sold 700 shares
@ $29.06, valued at
$20.3k
Exercised 717 options to buy
@ $4.09, valued at
$2.9k
Exercised 9,283 options to buy
@ $4.73, valued at
$43.9k
Exercised 100 options to buy
@ $4.73, valued at
$473 Exercised 700 options to buy
@ $4.73, valued at
$3.3k
|
|
08/31/2020 |
4
| Kelsey Stephen Michael (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns:
| Sold 800 shares
@ $29.01, valued at
$23.2k
Sold 814 shares
@ $29.014, valued at
$23.6k
Sold 118 shares
@ $29, valued at
$3.4k
Exercised 800 options to buy
@ $4.09, valued at
$3.3k
Exercised 118 options to buy
@ $4.09, valued at
$482.6 |
|
08/14/2020 |
4
| Kelsey Stephen Michael (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns:
| Sold 9,098 shares
@ $25.7899, valued at
$234.6k
Sold 702 shares
@ $26.7696, valued at
$18.8k
Sold 300 shares
@ $27.55, valued at
$8.3k
Sold 3,800 shares
@ $27.4037, valued at
$104.1k
Sold 1,100 shares
@ $28.0555, valued at
$30.9k
Exercised 10,100 options to buy
@ $4.09, valued at
$41.3k
Exercised 4,900 options to buy
@ $4.09, valued at
$20k
|
|
02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/12/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/20/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/06/2014 |
4
| Kelsey Stephen Michael (SVP of New Projects) has filed a Form 4 on MEDIVATION, INC.
Txns:
| Granted 3,500 shares
@ $0 |
|
06/18/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/07/2013 |
4
| Kelsey Stephen Michael (EVP, R&D, Chief Med Officer) has filed a Form 4 on GERON CORP
Txns:
| Disposed/sold 386,875 shares
@ $0 |
|
01/03/2013 |
4
| Kelsey Stephen Michael (EVP, R&D Head, CMO) has filed a Form 4 on GERON CORP
Txns:
| Disposed/sold 40,000 shares
@ $0 |
|
06/01/2012 |
4
| Kelsey Stephen Michael (EVP, R&D Head, CMO) has filed a Form 4 on GERON CORP
Txns:
| Sold 9,300 shares
@ $1.37, valued at
$12.7k
|
|
05/18/2012 |
4
| Kelsey Stephen Michael (EVP, R&D Head, CMO) has filed a Form 4 on GERON CORP
Txns:
| Granted 450,000 options to buy
@ $1.41, valued at
$634.5k
|
|
05/24/2011 |
4
| Kelsey Stephen Michael (EVP, R&D Head, CMO) has filed a Form 4 on GERON CORP
Txns:
| Granted 37,500 shares
@ $0 Granted 40,000 shares
@ $0 Granted 75,000 options to buy
@ $4.65, valued at
$348.8k
|
|
05/06/2011 |
4
| Kelsey Stephen Michael (EVP, CMO, Oncology) has filed a Form 4 on GERON CORP
Txns:
| Sold 14,163 shares
@ $4.83, valued at
$68.4k
|
|
|
|
|